These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 2663256

  • 21. The mechanisms of penicillamine, trientine, and zinc in the treatment of Wilson's disease.
    Yarze JC.
    Am J Gastroenterol; 1995 Jun; 90(6):1026. PubMed ID: 7771405
    [No Abstract] [Full Text] [Related]

  • 22. Treatment of Wilson's disease with triethylene tetramine hydrochloride (Trientine).
    Dubois RS, Rodgerson DO, Hambidge KM.
    J Pediatr Gastroenterol Nutr; 1990 Jan; 10(1):77-81. PubMed ID: 2324883
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Improvement of cardiovascular autonomic dysfunction following anti-copper therapy in Wilson's disease.
    Deguchi K, Sasaki I, Touge T, Tsukaguchi M, Ikeda K, Shimamura M, Urai Y, Watanabe S, Takeuchi H, Kuriyama S.
    J Neurol; 2005 Apr; 252(4):495-7. PubMed ID: 15726258
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Treatment of Wilson's disease (hepatolenticular degeneration) with penicillamine and low-copper diet.
    Goldstein NP, Tauxe WN, McCall JT, Gross JB, Randall RV.
    Trans Am Neurol Assoc; 1969 Apr; 94():34-7. PubMed ID: 5374484
    [No Abstract] [Full Text] [Related]

  • 28. Treatment of Wilson's disease with tetrathiomolybdate: V. Control of free copper by tetrathiomolybdate and a comparison with trientine.
    Brewer GJ, Askari F, Dick RB, Sitterly J, Fink JK, Carlson M, Kluin KJ, Lorincz MT.
    Transl Res; 2009 Aug; 154(2):70-7. PubMed ID: 19595438
    [Abstract] [Full Text] [Related]

  • 29. Comparative effectiveness of common therapies for Wilson disease: A systematic review and meta-analysis of controlled studies.
    Appenzeller-Herzog C, Mathes T, Heeres MLS, Weiss KH, Houwen RHJ, Ewald H.
    Liver Int; 2019 Nov; 39(11):2136-2152. PubMed ID: 31206982
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Penicillamine in Wilson's disease.
    Danks DM.
    Lancet; 1982 Aug 21; 2(8295):435-6. PubMed ID: 6124819
    [No Abstract] [Full Text] [Related]

  • 32. [Wilson's disease].
    Cramarossa L, D'Angelo D, D'Ascanio I, Ferri GB, Piane E.
    Recenti Prog Med; 1992 May 21; 83(5):255-61. PubMed ID: 1439104
    [Abstract] [Full Text] [Related]

  • 33. Tetrathiomolybdate anticopper therapy for Wilson's disease inhibits angiogenesis, fibrosis and inflammation.
    Brewer GJ.
    J Cell Mol Med; 2003 May 21; 7(1):11-20. PubMed ID: 12767257
    [Abstract] [Full Text] [Related]

  • 34. [Wilsons disease].
    Mareček Z, Brůha R.
    Vnitr Lek; 2013 Jul 21; 59(7):578-83. PubMed ID: 23909262
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [On hepatolenticular degeneration (Wilson's disease). 3. Hepatic localization of Cu64: scintigraphic and dynamic study before and after treatment with BAL and D-penicillamine].
    D'Addabbo A, Damato VD, Germinario L, Campanella G, Boccuni N.
    Acta Neurol (Napoli); 1971 Jul 21; 26(4):436-48. PubMed ID: 5132825
    [No Abstract] [Full Text] [Related]

  • 37. Interactions of zinc and molybdenum with copper in therapy of Wilson's disease.
    Brewer GJ.
    Nutrition; 1995 Jul 21; 11(1 Suppl):114-6. PubMed ID: 7749256
    [Abstract] [Full Text] [Related]

  • 38. Discontinuation of penicillamine in the absence of alternative orphan drugs (trientine-zinc): a case of decompensated liver cirrhosis in Wilson's disease.
    Ping CC, Hassan Y, Aziz NA, Ghazali R, Awaisu A.
    J Clin Pharm Ther; 2007 Feb 21; 32(1):101-7. PubMed ID: 17286794
    [Abstract] [Full Text] [Related]

  • 39. Can Wilson's disease patients be decoppered?
    Mason J, McQuaid A, Pheiffer H.
    Lancet; 1989 Jun 24; 1(8652):1455. PubMed ID: 2567467
    [No Abstract] [Full Text] [Related]

  • 40. Zinc therapy increases duodenal concentrations of metallothionein and iron in Wilson's disease patients.
    Sturniolo GC, Mestriner C, Irato P, Albergoni V, Longo G, D'Incà R.
    Am J Gastroenterol; 1999 Feb 24; 94(2):334-8. PubMed ID: 10022625
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.